OrbiMed’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,118,100
| Closed | -$32.5M | – | 132 |
|
|
2023
Q2 | $32.5M | Buy |
2,118,100
+373,800
| +21% | +$5.74M | 0.59% | 56 |
|
|
2023
Q1 | $39.2M | Buy |
1,744,300
+491,170
| +39% | +$11M | 0.77% | 43 |
|
|
2022
Q4 | $26.4M | Hold |
1,253,130
| – | – | 0.5% | 59 |
|
|
2022
Q3 | $30.9K | Buy |
1,253,130
+480,930
| +62% | +$11.9K | 0.57% | 57 |
|
|
2022
Q2 | $18.7K | Buy |
+772,200
| New | +$18.7K | 0.34% | 65 |
|
|
2021
Q2 | – | Sell |
-528,100
| Closed | -$13.2M | – | 173 |
|
|
2021
Q1 | $13.2M | Buy |
+528,100
| New | +$13.2M | 0.12% | 111 |
|